While the dose of the compound of the present invention or a pharmaceutically acceptable salt thereof or a prodrug thereof varies depending on the subject of administration, symptoms and other factors, a dose of about 0.01-500 mg is administered 1-3 times a day for oral administration to an adult patient with, for example, allergy, asthma, inflammation or cancer.